These findings may have relevance to design clinical interventions since GWAS has identified AIP1 (the DAB2IP gene) as a susceptibility gene for early onset of myocardial infarction, abdominal aortic aneurysm, peripheral vascular disease and pulmonary embolism. This evidence concerns the gene DAB2IP and pulmonary embolism.